ARTICLE | Clinical News
Zavesca miglustat regulatory update
March 15, 2010 7:00 AM UTC
FDA issued a complete response letter for an sNDA from Actelion for Zavesca miglustat to treat progressive neurological manifestations in patients with Niemann-Pick type C disease. The agency asked Ac...